ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 469 filers reported holding ENCOMPASS HEALTH CORP in Q2 2024. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $301,141 | -33.5% | 3,510 | -36.0% | 0.03% | -34.1% |
Q1 2024 | $453,116 | +22.1% | 5,487 | -1.3% | 0.04% | +13.9% |
Q4 2023 | $371,014 | -1.0% | 5,561 | -0.3% | 0.04% | -12.2% |
Q3 2023 | $374,786 | +6.2% | 5,580 | +7.1% | 0.04% | 0.0% |
Q2 2023 | $352,789 | +14.4% | 5,210 | -8.6% | 0.04% | +10.8% |
Q1 2023 | $308,266 | -6.6% | 5,698 | +3.3% | 0.04% | -9.8% |
Q4 2022 | $329,877 | +28.4% | 5,515 | -2.8% | 0.04% | +17.1% |
Q3 2022 | $257,000 | -17.6% | 5,675 | +2.0% | 0.04% | -12.5% |
Q2 2022 | $312,000 | -24.1% | 5,564 | -3.7% | 0.04% | -14.9% |
Q1 2022 | $411,000 | +24.5% | 5,779 | +14.4% | 0.05% | +20.5% |
Q4 2021 | $330,000 | +41.6% | 5,052 | +62.5% | 0.04% | +25.8% |
Q3 2021 | $233,000 | -10.0% | 3,108 | -6.3% | 0.03% | -13.9% |
Q2 2021 | $259,000 | -27.7% | 3,317 | -24.2% | 0.04% | -40.0% |
Q1 2021 | $358,000 | +9.8% | 4,375 | +11.1% | 0.06% | -3.2% |
Q4 2020 | $326,000 | +24.9% | 3,938 | -2.1% | 0.06% | +3.3% |
Q3 2020 | $261,000 | +4.0% | 4,022 | -0.6% | 0.06% | -3.2% |
Q2 2020 | $251,000 | +3.7% | 4,046 | +7.1% | 0.06% | -13.9% |
Q1 2020 | $242,000 | +18.6% | 3,779 | +28.1% | 0.07% | +44.0% |
Q4 2019 | $204,000 | – | 2,949 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
RK Capital | 115,800 | $7,525,000 | 2.13% |
Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |